Insider Transactions in Q1 2018 at Medtronic PLC (MDT)
Insider Transaction List (Q1 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2018
|
James T Lenehan Director |
SELL
Open market or private sale
|
Direct |
1,306
-2.7%
|
$108,398
$83.56 P/Share
|
|
Mar 13
2018
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,590
+3.18%
|
$79,500
$50.34 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,338
-51.62%
|
$3,186,702
$79.74 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,620
+18.53%
|
$2,965,820
$61.06 P/Share
|
|
Mar 05
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
12,479
-29.7%
|
$973,362
$78.36 P/Share
|
|
Mar 02
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
12,000
-22.22%
|
$936,000
$78.0 P/Share
|
|
Feb 18
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-3.47%
|
$122,176
$83.31 P/Share
|
|
Jan 09
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
78,526
-40.14%
|
$6,753,236
$86.21 P/Share
|
|
Jan 09
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
81,364
+19.08%
|
$2,929,104
$36.21 P/Share
|
|
Jan 05
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
26,158
-28.44%
|
$2,223,430
$85.0 P/Share
|
|
Jan 05
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
26,158
+22.14%
|
$1,621,796
$62.76 P/Share
|